Showing 1 - 6 of 6
Prescription scheme wins insurers' nod
Business, Nuntawun Polkuamdee, Published on 13/12/2025
» The Office of Insurance Commission (OIC) and the insurance industry have officially endorsed the government's "Sukkai Sabai Krabao" (Healthy Body, Comfortable Wallet) initiative, which allows patients treated at private hospitals to use their prescriptions at participating outside pharmacies.
JSP doubles investment in online sales
Business, Nuntawun Polkuamdee, Published on 17/10/2025
» MAI-listed JSP Pharmaceutical Manufacturing (Thailand), a leading distributor of medicines and nutritional supplements, is moving swiftly to capitalise on the surging popularity of the "Janey Live" phenomenon, doubling its investment in online sales channels to meet skyrocketing demand.
Stocks to benefit from Beijing's move
Business, Nuntawun Polkuamdee, Published on 24/01/2023
» Stocks in the tourism, aviation and pharmaceutical sectors are the major beneficiaries of China's announcement to allow group tours to visit 20 countries effective as of Feb 6, analysts said.
SET loses ground after 4% gain in August
Business, Nuntawun Polkuamdee, Published on 03/09/2022
» RECAP: Global stock markets lost ground this week as investors assessed the impact of more US interest rate hikes and tensions over Taiwan. External factors remained the key factors affecting market sentiment in Asia including Thailand.
JP makes impressive MAI trading debut
Business, Nuntawun Polkuamdee, Published on 03/11/2021
» Shares of JSP Pharmaceutical Manufacturing (Thailand) (JP), a medicine and nutritional supplements distributor, opened trading at 9.40 baht on the Market for Alternative Investment (MAI) on Tuesday, up 34.29% from the initial public offering price (IPO) at 7 baht.
KINN eyes B400m in revenue
Business, Nuntawun Polkuamdee, Published on 30/03/2019
» KINN Worldwide, Thailand's leading cordyceps sinensis vendor, aims to build total revenue to around 400 million baht in four years through new dietary supplement production, with an objective to list on the Market for Alternative Investment.